Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3214

1.

[Liver injury induced by immune checkpoint inhibitor-therapy : Example of an immune-mediated drug side effect].

Straub BK, Ridder DA, Schad A, Loquai C, Schattenberg JM.

Pathologe. 2018 Oct 11. doi: 10.1007/s00292-018-0519-6. [Epub ahead of print] Review. German.

PMID:
30310977
2.

Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage.

Jabbour E, Sasaki K, Ravandi F, Huang X, Short NJ, Khouri M, Kebriaei P, Burger J, Khoury J, Jorgensen J, Jain N, Konopleva M, Garcia-Manero G, Kadia T, Cortes J, Jacob J, Montalbano K, Garris R, O'Brien S, Kantarjian H.

Cancer. 2018 Oct 11. doi: 10.1002/cncr.31720. [Epub ahead of print]

PMID:
30307611
3.

Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure.

Richardson PG, Grupp SA, Pagliuca A, Krishnan A, Ho VT, Corbacioglu S.

Int J Hematol Oncol. 2017 Nov;6(3):75-93. doi: 10.2217/ijh-2017-0015. Epub 2017 Aug 11. Review.

4.

Good response to PAH-targeted drugs in a PVOD patient carrying Biallelic EIF2AK4 mutation.

Liang L, Su H, Ma X, Zhang R.

Respir Res. 2018 Oct 1;19(1):192. doi: 10.1186/s12931-018-0900-2.

5.

SINUSOIDAL OBSTRUCTION SYNDROME / VENO-OCCLUSIVE DISEASE AFTER AUTOLOGOUS OR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN: a retrospective study of the AIEOP-HSCT (Italian Hematology-Oncology Association-Hematopoietic Stem Cell transplantation) Group.

Faraci M, Bertaina A, Luksch R, Calore E, Lanino E, Saglio F, Prete A, Menconi MC, De Simone G, Tintori V, Cesaro S, Santarone S, Orofino MG, Locatelli F, Zecca M.

Biol Blood Marrow Transplant. 2018 Sep 25. pii: S1083-8791(18)30594-9. doi: 10.1016/j.bbmt.2018.09.027. [Epub ahead of print]

PMID:
30266674
6.

Economic Burden of Veno-occlusive Disease in Patients With B-cell Acute Lymphoblastic Leukemia in the United States.

Zhang X, Song X, Lopez-Gonzalez L, Jariwala-Parikh K, Romanov V, Cong Z.

Clin Ther. 2018 Oct;40(10):1711-1719.e1. doi: 10.1016/j.clinthera.2018.08.005. Epub 2018 Sep 7.

7.

Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide.

Schoch LK, Cooke KR, Wagner-Johnston ND, Gojo I, Swinnen LJ, Imus P, Fuchs EJ, Levis M, Ambinder RF, Jones RJ, Gladstone DE.

Blood Adv. 2018 Sep 11;2(17):2226-2229. doi: 10.1182/bloodadvances.2018019208.

8.

Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma.

Schechter T, Perez-Albuerne E, Lin TF, Irwin MS, Essa M, Desai AV, Frangoul H, Yanik G, Dupuis LL, Jacobsohn D, Kletzel M, Ranalli M, Soni S, Seif AE, Grupp S, Dvorak CC.

Bone Marrow Transplant. 2018 Sep 4. doi: 10.1038/s41409-018-0298-y. [Epub ahead of print]

PMID:
30181580
9.

Liver complications following treatment of hematologic malignancy with anti-cd22-calicheamicin (Inotuzumab Ozogamicin).

McDonald GB, Freston JW, Boyer JL, DeLeve LD.

Hepatology. 2018 Aug 18. doi: 10.1002/hep.30222. [Epub ahead of print]

PMID:
30120894
10.

Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children.

Philippe M, Neely M, Rushing T, Bertrand Y, Bleyzac N, Goutelle S.

Bone Marrow Transplant. 2018 Aug 14. doi: 10.1038/s41409-018-0281-7. [Epub ahead of print]

PMID:
30108322
11.

Co-existence of vocal cord dysfunction with pulmonary conditions other than asthma: A case series.

Fajt ML, Birnie KM, Trejo Bittar HE, Petrov AA.

Respir Med Case Rep. 2018 Aug 3;25:104-108. doi: 10.1016/j.rmcr.2018.08.001. eCollection 2018.

12.

Gemtuzumab Ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report of Berlin-Frankfurt-Münster study group.

Niktoreh N, Lerius B, Zimmermann M, Gruhn B, Escherich G, Bourquin JP, Dworzak M, Sramkova L, Rossig C, Creutzig U, Reinhardt D, Rasche M.

Haematologica. 2018 Aug 9. pii: haematol.2018.191841. doi: 10.3324/haematol.2018.191841. [Epub ahead of print]

13.

Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.

Roeker LE, Kim HT, Glotzbecker B, Nageshwar P, Nikiforow S, Koreth J, Armand P, Cutler C, Alyea EP, Antin JH, Richardson PG, Soiffer RJ, Ho VT.

Biol Blood Marrow Transplant. 2018 Aug 3. pii: S1083-8791(18)30428-2. doi: 10.1016/j.bbmt.2018.07.039. [Epub ahead of print]

PMID:
30081073
14.

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase 3 ALFA-0701 trial.

Lambert J, Pautas C, Terré C, Raffoux E, Turlure P, Caillot D, Legrand O, Thomas X, Gardin C, Gogat-Marchant K, Rubin SD, Benner RJ, Bousset P, Preudhomme C, Chevret S, Dombret H, Castaigne S.

Haematologica. 2018 Aug 3. pii: haematol.2018.188888. doi: 10.3324/haematol.2018.188888. [Epub ahead of print]

15.

New Ultrasound Techniques Challenge the Diagnosis of Sinusoidal Obstruction Syndrome.

Dietrich CF, Trenker C, Fontanilla T, Görg C, Hausmann A, Klein S, Lassau N, Miquel R, Schreiber-Dietrich D, Dong Y.

Ultrasound Med Biol. 2018 Nov;44(11):2171-2182. doi: 10.1016/j.ultrasmedbio.2018.06.002. Epub 2018 Jul 31. Review.

PMID:
30076031
16.

[Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].

Liu W, Li Y, Qiu ZX, Yin Y, Sun YH, Xu WL, Wang Q, Liang ZY, Dong YJ, Wang LH, Cen QN, Wang MJ, Wang WS, Ou JP, Ren HY.

Zhonghua Nei Ke Za Zhi. 2018 Aug 1;57(8):576-581. doi: 10.3760/cma.j.issn.0578-1426.2018.08.008. Chinese.

PMID:
30060329
17.

[Severe Liver Injury Due to Sinusoidal Obstruction Syndrome Induced by Oxaliplatin in a Patient with Resectable Colorectal Liver Metastases].

Tominaga K, Kurumiya Y, Sekoguchi E, Kobayashi S, Kawai K, Kiriyama M.

Gan To Kagaku Ryoho. 2018 Jun;45(6):989-992. Japanese.

PMID:
30026429
18.

Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab.

Suffredini DA, Lee JM, Peer CJ, Pratt D, Kleiner DE, Elinoff JM, Solomon MA.

BMC Pulm Med. 2018 Jul 11;18(1):112. doi: 10.1186/s12890-018-0681-x.

19.

[A clinical analysis of hepatic veno-occlusive disease after hematopoietic stem cell transplantation].

Qin CJ, Liu LJ, Zhang ZM, Luo L, Lai YR, Li QC.

Zhonghua Nei Ke Za Zhi. 2018 Jul 1;57(7):483-486. doi: 10.3760/cma.j.issn.0578-1426.2018.07.003. Chinese.

PMID:
29996265
20.

Fulminant hepatitis due to very severe sinusoidal obstruction syndrome (SOS/VOD) after autologous peripheral stem cell transplantation: a case report.

Tavernier E, Chalayer E, Cornillon J, Pouvaret A, Martignoles JA, Casteillo F, Terreaux J, Daguenet E, Guyotat D.

BMC Res Notes. 2018 Jul 3;11(1):436. doi: 10.1186/s13104-018-3533-0.

Supplemental Content

Loading ...
Support Center